Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis

被引:43
|
作者
Behbehani, Raed [1 ,2 ]
Abu Al-Hassan, Abdullah [1 ]
Al-Salahat, Ali [1 ]
Sriraman, Devarajan [3 ]
Oakley, J. D. [4 ]
Alroughani, Raed [2 ,5 ]
机构
[1] Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Kuwait, Kuwait
[2] Dasman Inst, Neurol Clin, Dasman, Kuwait
[3] Dasman Inst, Natl Dasman Diabet Biobank, Dasman, Kuwait
[4] Voxeleron LLC, Pleasanton, CA USA
[5] Amiri Hosp, Div Neurol, Sharq, Kuwait
来源
PLOS ONE | 2017年 / 12卷 / 02期
关键词
FIBER LAYER THICKNESS; PATHOLOGY; NEURITIS; MS;
D O I
10.1371/journal.pone.0172120
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Optical coherence tomography (OCT) with retinal segmentation analysis is a valuable tool in assessing axonal loss and neuro-degeneration in multiple sclerosis ( MS) by in-vivo imaging, delineation and quantification of retinal layers. There is evidence of deep retinal involvement in MS beyond the inner retinal layers. The ultra-structural retinal changes in MS in different MS phenotypes can reflect differences in the pathophysiologic mechanisms. There is limited data on the pattern of deeper retinal layer involvement in progressive MS (PMS) versus relapsing remitting MS (RRMS). We have compared the OCT segmentation analysis in patients with relapsing-remitting MS and progressive MS. Methods Cross-sectional study of 113 MS patients (226 eyes) (29 PMS, 84 RRMS) and 38 healthy controls (72 eyes). Spectral domain OCT (SDOCT) using the macular cube acquisition protocol (Cirrus HDOCT 5000; Carl Zeiss Meditec) and segmentation of the retinal layers for quantifying the thicknesses of the retinal layers. Segmentation of the retinal layers was carried out utilizing Orion software (Voxeleron, USA) for quantifying the thicknesses of individual retinal layers. Results The retinal nerve finer layer (RNFL) (p = 0.023), the ganglion-cell/inner plexiform layer (GCIPL) (p = 0.006) and the outer plexiform layer (OPL) (p = 0.033) were significantly thinner in PMS compared to RRMS. There was significant negative correlation between the outer nuclear layer (ONL) and EDSS (r = -0.554, p = 0.02) in PMS patients. In RRMS patients with prior optic neuritis, the GCIPL correlated negatively (r = -0.317; p = 0.046), while the photoreceptor layer (PR) correlated positively with EDSS (r = 0.478; p = 0.003). Conclusions Patients with PMS exhibit more atrophy of both the inner and outer retinal layers than RRMS. The ONL in PMS and the GCIPL and PR in RRMS can serve as potential surrogate of disease burden and progression (EDSS). The specific retinal layer predilection and its correlation with disability may reflect different pathophysiologic mechanisms and various stages of progression in MS.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Human herpesvirus-6 and multiple sclerosis:: relapsing-remitting versus secondary progressive
    Alvarez-Lafuente, Roverto
    de las Heras, Virginia
    Garcia-Montojo, Marto
    Bartolome, Manuel
    Arroyo, Rafael
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (05) : 578 - 583
  • [22] Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis
    Koch, M. W.
    Ilnytskyy, Y.
    Golubov, A.
    Metz, L. M.
    Yong, V. W.
    Kovalchuk, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (04) : 651 - 658
  • [23] Disease modifying therapy in relapsing remitting multiple sclerosis reduces inner nuclear layer volumes as measured by optical coherence tomography
    Knier, B.
    Aly, L.
    Berthele, A.
    Buck, D.
    Muehlau, M.
    Hemmer, B.
    Korn, T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 510 - 510
  • [24] Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis
    Ge, YL
    Grossman, RI
    Udupa, JK
    Wei, LG
    Mannon, LJ
    Polansky, M
    Kolson, DL
    RADIOLOGY, 2000, 214 (03) : 665 - 670
  • [25] Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis
    Piedrabuena, R.
    Bittar, M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [26] Optical Coherence Tomography, Retinal Atrophy, and Neurodegeneration in Progressive Multiple Sclerosis
    Bennett, Jeffrey L.
    NEUROLOGY, 2023, 101 (10) : 420 - 421
  • [27] Optical coherence tomography and visual evoked potentials in progressive multiple sclerosis
    Guerrieri, S.
    Girola, S.
    Pisa, M.
    Huang, S. C.
    Santangelo, R.
    Moiola, L.
    Martinelli, V.
    Comi, G.
    Leocani, L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 483 - 484
  • [28] Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Terzi, Murat
    Ozer, Bilge
    Turkoglu, Recai
    Karabudak, Rana
    Efendi, Husnu
    Soysal, Aysun
    Sevim, Serhan
    Altintas, Ayse
    Kurne, Asli
    Akcali, Aylin
    Akman, Gulsen
    Yuceyar, Nur
    Balci, Belgin Petek
    Ekmekci, Ozgul
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Altunrende, Burcu
    Turan, Omer Faruk
    GozubatikCelik, Gokcen
    Kale, Nilufer
    Koseoglu, Mesrure
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [29] Predictors of Conversion to Secondary Progressive Multiple Sclerosis in Patients with Relapsing-Remitting Multiple Sclerosis
    Kappos, L.
    Meier, D. P.
    Tomic, T.
    Haring, D.
    Bakshi, R.
    Meinert, R.
    Giovannoni, G.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 447 - 447
  • [30] Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
    Chalkias, Ioannis-Nikolaos
    Bakirtzis, Christos
    Pirounides, Demetrios
    Boziki, Marina Kleopatra
    Grigoriadis, Nikolaos
    HEALTHCARE, 2022, 10 (08)